York PhD project P14: Sustainable 3D synthesis for medicinal chemistry

York PhD project P14: Sustainable 3D synthesis for medicinal chemistry

Executive Verdict

Can computationally selected three-dimensional building blocks offer useful medicinal-chemistry shapes while making their complete synthetic routes more sustainable? P14 connects those two tests: structural usefulness and the environmental burden of obtaining the material. It suits a synthesis-led applicant willing to develop computational and quantitative sustainability skills. A promising scientific fit still needs a written four-year overseas-fee agreement before accepting an offer.

P14 is a high-value project with an unusually clear scientific chain. The official 2027 project list names Peter O'Brien at York and Fernanda Duarte at Oxford as supervisors and MSD as industrial partner. It proposes computational enumeration of rigid, bifunctional 3-D chemical space, experimental access to selected building blocks, whole-route sustainability critique, and medicinal-chemistry applications including bioisosteres, linkers, scaffold hopping, fragment elaboration and unnatural amino acids. Recent work from the two supervisory environments provides direct evidence for both the experimental and computational halves of that plan.

Programme information lists P14 for the 2027/28 intake. The first-round deadline is Friday 13 November 2026 at 12 noon; the material does not state a time zone. CDT information also mentions a January 2027 round, but P14's availability after interview-based allocation is not guaranteed. The saved material does not establish whether P14 is currently available.

For a mainland Chinese applicant, the core admissions answer is positive but conditional: international applicants can compete, yet only up to 30% of funded places can be assigned internationally. The larger concern is financial closure. The programme calls its awards fully funded, but its own international FAQ recommends seeking a scholarship for the difference between home and overseas fees, while York's previous-cohort CSHP terms cover fees at the UK rate. A four-year award is only financially safe once the individual studentship or offer letter states the overseas tuition contribution for all four years.

School, Programme, and Location Signal

The Chemical Synthesis for a Healthy Planet CDT is an EPSRC-backed collaboration between Oxford and York. Its programme home describes a four-year degree, a four-month cohort training phase, more than forty participating academics, ten industrial partners and ten SMEs. Students then complete a 44-month substantive project. This matters because P14 spans synthetic chemistry, computational design, green metrics and industrial medicinal chemistry; the CDT structure provides broader training than a single-laboratory doctorate normally would.

The taught-course description covers sustainable synthesis, analytical chemistry, responsible research and innovation, scientific communication, project management, careers, intellectual property and entrepreneurship. Much of the training is delivered in Oxford, with time at York's Green Chemistry Centre of Excellence. Applicants should confirm the 2027 calendar and how cross-site travel is organised, but the programme says away-institution accommodation during taught training is covered.

York is a credible primary base. Its Chemistry postgraduate research page reports ninth in the UK for research in its REF-based comparison, Athena Swan Gold status, and multiple doctoral training programmes. The PhD in Chemistry page confirms departmental analytical services, dedicated research space and a formal minimum of a relevant 2:1-equivalent degree. It also warns that funded awards are competitive and usually require a high 2:1 or First-class profile.

The main programme-scale limitation is scarcity. The application page says up to sixteen four-year studentships are available each year, but only three or four are normally based at York. Project allocation is ranking-based: the highest-scoring candidates receive their preferred projects first. Listing credible second and third choices is therefore prudent, but the statement should still make a precise P14 case.

Supervisor and Lab Assessment

Supervisor Research Directions

Peter O'Brien is a direct match to the experimental core. His York profile describes synthetic-method development and medicinal chemistry, including stereospecific sp3-sp2 cross-coupling, 3-D fragments and fragment elaboration. This is not merely thematic proximity: the official P14 description explicitly builds from his group's rigid cyclopropane and cyclobutane building-block work.

Fernanda Duarte provides a genuinely complementary rather than duplicative contribution. Her Oxford profile covers computational organic chemistry, reaction mechanisms, catalyst and synthesis design, QM/DFT, molecular dynamics, machine learning and automated tools. P14's value depends on using computation to reduce unproductive experimental search while still testing whether prioritised candidates can actually be made and characterised.

The supervision design looks strong on paper, but the public pages do not give a weekly division of labour. An applicant should ask who provides day-to-day computational mentoring, how frequently Duarte meets the York-based student, and how joint decisions on candidate selection, authorship and negative results are made.

Recent Important Publications

1. Modular Synthetic Platform for the Elaboration of Fragments in Three Dimensions for Fragment-Based Drug Discovery (JACS, 2025). O'Brien and collaborators report nine rigid, bifunctional, sp3-rich building blocks that enable systematic conversion of 2-D fragment hits into 3-D lead-like compounds. This is the closest direct precursor to P14. It demonstrates feasibility, while also defining the novelty burden: the doctorate must deliver a more sustainable and computationally prioritised next generation rather than repeat the platform.
2. Design, modular synthesis and screening of 58 shape-diverse 3-D fragments (Chemical Science, 2025). The work reports a synthetically enabled fragment collection occupying under-represented 3-D shape space and includes structural-screening hits. It supports biological relevance, but also shows that synthesis alone does not establish medicinal value; useful validation depends on property, assay or structural collaborations.
3. The Heterocycle Isostere Explorer: A Computational Tool for the Discovery of Novel Aromatic Heterocyclic Isosteres (Journal of Medicinal Chemistry, 2026). Duarte co-authored a vector-based, open-source tool that searches more than 500,000 enumerated substituted heterocycles using shape, electrostatic and physicochemical descriptors. It is a strong precedent for P14's computational prioritisation, while making an important distinction: predicted similarity is a selection tool, not experimental evidence of accessibility or biological performance. Together, these papers make the project more credible than a speculative green-chemistry proposal. They also reveal its central research question: can a computation-to-synthesis workflow select structurally useful 3-D building blocks whose complete access route is materially more sustainable?

Lab, Resources, and Collaboration Environment

York's Green Chemistry Centre facilities include purpose-built laboratories and an industrial engagement facility, with access to NMR, HPLC, GC, mass spectrometry, IR, thermal methods and X-ray techniques. The department's analytical facilities list seven liquid-state multinuclear NMR instruments, solid-state NMR, comprehensive mass spectrometry and open-access chromatography. These are appropriate institutional capabilities for synthetic route development and compound characterisation.

Institutional availability is not the same as a P14 resource commitment. Before accepting, ask for the project's annual consumables and analytical-service budget, expected instrument turnaround, compute and software access, and which downstream physicochemical or biological assays are funded. The answer should distinguish routine departmental access from collaborator-dependent work.

MSD is officially named as industrial partner, which is a positive signal for medicinal relevance. However, the public page does not identify an MSD co-supervisor, placement, compound collection, proprietary dataset, assay package or guaranteed contact schedule. The applicant should therefore treat the partnership as promising but undefined. Written clarification should cover supervision time, placement expectations, IP ownership, confidentiality, publication review, compound or data access, and whether negative results can remain in the thesis.

Research Direction and Field Outlook

Field Momentum

Three-dimensional and sp3-rich scaffolds remain attractive because they can explore vectors and shapes that conventional flat aromatic fragments do not. P14 is well positioned within that field because it connects molecular design to synthetic enablement: candidates are only useful if medicinal chemists can incorporate them reliably and control their exit vectors.

The more distinctive element is sustainability. The project proposes replacing precious-metal-dependent handles with nickel-mediated coupling and selecting among geometrically similar building blocks based on route efficiency. That is a credible hypothesis, but it should not be reduced to “nickel equals green.” The ACS green-chemistry tools treat solvents, purification, reagents, energy, resources and Process Mass Intensity as major contributors, while the twelve principles require attention to prevention, hazard, energy, catalysis and lifecycle considerations. P14 will be strongest if it prespecifies complete-route comparators and quantifies trade-offs rather than using a single metal choice as a proxy.

Potential Research Angles

• Decision-aware enumeration: rank candidates jointly by vector novelty, medicinally relevant descriptors, predicted accessibility and route sustainability rather than geometric diversity alone.
• Prospective validation: record which computationally prioritised candidates survive expert accessibility review, synthesis, purification and characterisation, creating evidence about model utility and failure modes.
• Whole-route comparison: compare candidate routes using material intensity, solvent and isolation burden, energy, hazard and waste, with explicit reference routes.
• Application-specific ranking: define different design objectives for bioisosteres, linkers, scaffold hopping, fragment elaboration and unnatural amino acids instead of claiming one universal score.
• Robustness as sustainability: include reproducibility, isolation burden and reasonable scale in candidate selection, because an elegant low-yield or chromatography-heavy route can undermine an apparently greener catalyst choice.
• Industry-facing validation: agree with MSD which properties and demonstrations are decision-useful while protecting a publishable, methodologically coherent thesis. These are research-design options rather than experimental instructions. The student should expect substantial laboratory work, but the public evidence does not justify assuming any particular operational protocol.

Career and Market Outlook

The strongest graduate profile would combine rigorous organic synthesis, modern analytical interpretation, molecular or cheminformatics literacy, quantitative sustainability assessment and experience working across academic and industrial boundaries. That profile is relevant to medicinal chemistry, computational chemistry, sustainable process discovery, CRO and pharmaceutical R&D, analytical science and postdoctoral research.

The UK Life Sciences Sector Plan prioritises pharmaceutical R&D, advanced manufacturing and interdisciplinary skills, including specialist AI capability. This supports the direction of travel but is not an employment guarantee. Career value will depend on tangible outputs: well-characterised chemistry, transparent green metrics, reusable code or data, and evidence that candidates were prioritised or rejected for defensible reasons.

Funding, Application, and Living Cost

Application information identifies P14 for the 2027/28 intake. The first-round deadline is Friday 13 November 2026 at 12 noon; the time zone is not specified, and current P14 availability is unverified.

• The York application uses one Chemistry application, lists project choices in preference order, and does not require a full project proposal. York recruitment information asks for a 1000-word personal statement explaining research interest/experience, ending with the 1–2–3 ranked substantive-project choices, university transcripts and two academic/professional referee contacts. York applicants also complete the CSHP EDI form.
• York requires two referees, with references submitted by the deadline.
• The CDT assesses academic achievement, references and motivation/fit with equal weight.
• The interview includes a presentation on prior research, discussion of a supplied paper, motivation/project questions and a synthetic-chemistry problem-solving exercise. Funding needs a more cautious reading. The CSHP FAQ gives a £21,805 annual stipend for 2026/27 and full four-year fees for eligible home students. The international FAQ says international applicants can receive full funding within the UKRI limit of up to 30% of funded places, but recommends applying for a scholarship covering the difference in course fees. York's CSHP page for the previous cohort explicitly describes research costs and tuition fees at the UK rate. Meanwhile, York's international research-fee table lists Chemistry at £30,950 per year for 2026/27, subject to later increases.

The correct decision label is therefore: eligible to compete, but funding not yet closed for a Chinese applicant. Ask for a written 2027/28 award statement covering the overseas tuition contribution in each of four years, stipend and uprating, research costs, cross-site travel and accommodation, and any treatment of visa, immigration-health-surcharge and relocation costs.

Living costs appear manageable only after the fee issue is removed. York's 2026/27 postgraduate accommodation costs roughly £9,486 to £11,424 for a 51-week contract with bills included. That consumes a substantial share of the current stipend benchmark before food, travel and personal costs. Prices will change for 2027/28, so use the figures for scenario planning rather than as a promise.

Applicant Fit and Preparation

Best suited for

• An applicant with strong hands-on synthetic-organic research, preferably involving multi-step route reasoning and rigorous characterisation.
• Someone who can interpret 3-D molecular structure, exit vectors and medicinally relevant physicochemical properties without treating computation as a black box.
• A candidate able to compare routes quantitatively using material, solvent, waste, hazard and energy evidence.
• An applicant comfortable learning Python or cheminformatics and collaborating with a computational group.
• Someone who can explain industrial relevance while retaining scientific independence and publication discipline. For applicants educated in China, York's country guidance normally expects a recognised bachelor's degree plus a relevant master's or research experience for research degrees; institutional standing and marks are assessed case by case. The formal Chemistry minimum is a 2:1 equivalent, but a competitive file should look closer to a strong First/high 2:1 profile with substantive research evidence.

May need caution if

• Your experience is purely computational and you do not want a laboratory-intensive doctorate.
• You enjoy synthesis but do not want to engage with code, descriptors or quantitative sustainability metrics.
• You need guaranteed full overseas funding before applying rather than before accepting.
• You require a precisely defined biological target or assay package; P14 publicly emphasises building-block platform development, not one therapeutic programme.
• You are uncomfortable with possible industrial confidentiality, IP review or cross-institution supervision.
• You want a narrow thesis: the five advertised application areas can become over-broad unless core and optional deliverables are agreed early.

Skills and evidence to strengthen

The personal statement should use concrete evidence rather than generic enthusiasm. A strong version would show:

1. one synthetic research problem you owned, including how evidence changed your route decisions;
2. confident interpretation of NMR, MS and chromatography rather than a list of instruments;
3. a small reproducible computational or descriptor-based analysis, even if your primary identity is experimental;
4. a whole-route sustainability comparison that goes beyond yield or catalyst identity;
5. a critical reading of one of the three core papers and a specific, non-procedural follow-on question;
6. why the O'Brien-Duarte pairing and MSD setting are necessary for your goal;
7. a credible second and third project choice without making P14 sound interchangeable. York's 2027/28 English requirements list IELTS 6.0 overall with no component below 5.5 for Chemistry, plus published equivalents. A specific offer may impose conditions. A Chinese national should also plan for ATAS: under the current UK rules, research-level Chemistry is listed and China is not exempt. The final course CAH code and York's offer wording are decisive.

Risks and Questions to Verify

High-priority questions

1. Will the 2027/28 studentship cover the full overseas Chemistry tuition fee for a mainland Chinese appointee in every one of the four years, and will this appear in the award letter?
2. What is the 2027/28 stipend and uprating rule, and which Oxford-York travel and accommodation costs are prepaid or reimbursed?
3. Who is the named MSD co-supervisor, what time commitment is agreed, and is a placement or secondment guaranteed?
4. What compounds, property data, assays or medicinal-chemistry feedback will MSD provide, and what is only a possible future contribution?
5. What are the IP ownership, confidentiality, publication-review and negative-result publication terms?
6. Which computational tools, databases, licences and compute resources are committed, and who gives day-to-day computational support?
7. Which quantitative sustainability metrics and comparator routes will be prespecified, beyond a qualitative twelve-principles critique?
8. What P14-specific consumables and analytical-service budget is available for NMR, chromatography, mass spectrometry and crystallography?

Medium-priority questions

1. Which of the five medicinal-chemistry application areas is the core thesis validation target, and which are stretch goals?
2. Are physicochemical or biological assays part of P14, and which group or partner owns delivery and timing?
3. How do York and Oxford supervisors divide weekly contact, progress review, candidate-selection decisions and authorship?
4. What project is the most scientifically coherent backup if P14 is allocated after the November round?
5. What York course title and CAH code will be used, and when should ATAS preparation begin?
6. How are unsuccessful computational candidates and unsuccessful chemistry captured so the thesis remains publishable and decision-useful?

Evidence and Sources

The three cited papers support different parts of P14's rationale: experimental 3D-fragment synthesis, shape-diverse fragment screening and computational isostere selection. Their results support the research foundation but do not establish that P14's new candidates will be synthesised sustainably or prove useful. Infrastructure listings show institutional capability rather than project-specific allocation. The £21,805 stipend and £30,950 overseas fee are 2026/27 references, not confirmed P14 award terms. Project enquiries: peter.obrien@york.ac.uk; general CDT enquiries: cshp-cdt@chem.ox.ac.uk or chem-env-pgr@york.ac.uk. Enquiries do not replace the York application.

• Official P14 listing and 2027 project portfolio
• CSHP application page and current deadline
• CSHP admissions, allocation, interview and funding FAQs
• CSHP international funding and interview FAQ
• CSHP programme overview
• CSHP taught course
• Oxford announcement of the EPSRC CDT
• York CSHP studentship page
• York PhD in Chemistry
• York Chemistry postgraduate research environment
• York guidance for applicants from China
• York postgraduate research English requirements
• York international postgraduate research fees
• York postgraduate accommodation
• UK ATAS rules
• Peter O'Brien profile
• Fernanda Duarte profile
• York announcement on the 3-D drug-discovery platform
• JACS 2025 modular 3-D elaboration platform
• Chemical Science 2025 shape-diverse 3-D fragments
• Journal of Medicinal Chemistry 2026 Heterocycle Isostere Explorer
• York GCCE facilities
• York Chemistry analytical facilities
• ACS green chemistry research tools
• ACS twelve principles of green chemistry
• UK Life Sciences Sector Plan